A Two-Part Open-Label Single-Arm Phase 1/2 Study of Safety Pharmacokinetics and Efficacy of Telaprevir in Combination With Peginterferon alfa-2b and Ribavirin in Pediatric Subjects Aged 3 to 17 Infected With Genotype 1 Hepatitis C Virus
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The study is being done to learn more about the safety and the effectiveness of using Telaprevir in combination with two other medications to treat chronic hepatitis C in children.
Description
The study is being done to learn more about the safety and the effectiveness of using Telaprevir in combination with two other medications to treat chronic hepatitis C in children.
Details
| Condition | Hepatitis C |
|---|---|
| Age | 3years - 17years |
| Clinical Study Identifier | TX2898 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.